Published in Br J Pharmacol on October 01, 1984
Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice. J Physiol (1987) 1.27
Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci U S A (1987) 1.22
Fetal cardiovascular, metabolic and endocrine responses to acute hypoxaemia during and following maternal treatment with dexamethasone in sheep. J Physiol (2005) 1.01
The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog. Br J Pharmacol (1987) 0.99
Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail. Br J Pharmacol (1990) 0.98
Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: Neuropeptide and morphologic changes. Heart Rhythm (2015) 0.97
Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein. Br J Pharmacol (1999) 0.96
Modulation of cholinergic neurotransmission in guinea-pig trachea by neuropeptide Y. Br J Pharmacol (1988) 0.93
Actions of neuropeptide Y on innervated and denervated rat tail arteries. J Physiol (1987) 0.93
Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats. J Physiol (2004) 0.89
Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling. Microcirculation (2013) 0.87
Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders. Neurobiol Stress (2015) 0.87
Neuropeptide Y overflow and metabolism in skeletal muscle arterioles. J Physiol (2011) 0.87
Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors. Br J Pharmacol (1996) 0.87
Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries. Br J Pharmacol (1988) 0.86
Neuropeptide Y: a powerful modulator of epithelial ion transport. Br J Pharmacol (1986) 0.85
Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides. Am J Physiol Regul Integr Comp Physiol (2013) 0.85
Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium. Br J Pharmacol (1991) 0.84
Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review. Integr Blood Press Control (2011) 0.84
Comparison of the effects of neuropeptide Y and noradrenaline on rat gastric mucosal blood flow and integrity. Br J Pharmacol (1991) 0.84
Enhancement by neuropeptide Y (NPY) of the dihydropyridine-sensitive component of the response to alpha 1-adrenoceptor stimulation in rat isolated mesenteric arterioles. Br J Pharmacol (1990) 0.84
Effects of neuropeptide Y and calcitonin gene-related peptide on sheep coronary artery rings under oxygenated, hypoxic and simulated myocardial ischaemic conditions. Br J Pharmacol (1990) 0.83
The actions of neuropeptide Y and peptide YY on the hepatic arterial and portal vascular beds of the anaesthetized dog. Br J Pharmacol (1988) 0.83
Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study. Am J Cardiovasc Dis (2011) 0.83
The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors. Br J Pharmacol (2003) 0.82
Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U)receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors. Biochem J (1997) 0.81
Interaction of prostanoid EP₃ and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE₂. Br J Pharmacol (2011) 0.80
Neuropeptide Y and neurovascular control in skeletal muscle and skin. Am J Physiol Regul Integr Comp Physiol (2009) 0.79
Modulation of sympathetic neurotransmission by neuropeptide Y Y2 receptors in rats and guinea pigs. Exp Brain Res (2006) 0.78
Neuropeptide Y modulates ATP-induced increases in internal calcium via the adenylate cyclase/protein kinase A system in a human neuroblastoma cell line. Biochem J (1997) 0.78
Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate). Br J Pharmacol (1992) 0.78
Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries. Br J Pharmacol (2004) 0.78
The role of neuropeptide Y in the ovine fetal cardiovascular response to reduced oxygenation. J Physiol (2003) 0.77
The effects of neuropeptide Y on myocardial contractility and coronary blood flow. Br J Pharmacol (1991) 0.77
Effects of vasoactive neuropeptides on human saphenous vein. Br Heart J (1992) 0.77
Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney. Br J Pharmacol (1991) 0.77
Sympathetic control of reflex cutaneous vasoconstriction in human aging. J Appl Physiol (1985) (2015) 0.77
Modulatory effect of neuropeptide Y on acetylcholine-induced oedema and vasoconstriction in isolated perfused lungs of rabbit. Br J Pharmacol (1994) 0.75
Pharmacology of the coronary circulation. Can J Anaesth (1987) 0.75
Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev (1979) 10.73
Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (1982) 4.06
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A (1982) 2.89
Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand (1982) 2.23
Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regul Pept (1983) 1.29
Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett (1983) 1.17
Neuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the rat. Acta Physiol Scand (1983) 1.07
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
Cerebral autoregulation. Cerebrovasc Brain Metab Rev (1990) 5.13
Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci U S A (1994) 4.56
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol (1990) 3.25
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol (1993) 3.07
Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1986) 2.46
Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci U S A (1976) 2.45
Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept (1984) 2.27
Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand (1983) 2.20
Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A (2001) 2.11
Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept (1986) 2.05
Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology (1983) 1.90
Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia (1997) 1.78
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol (1988) 1.77
A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature (1981) 1.76
Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia (1976) 1.74
Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain (1994) 1.72
Localization of substance P-like immunoreactivity in mouse gut. Histochemistry (1975) 1.71
Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia (1996) 1.69
Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A (1986) 1.65
Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J Comp Neurol (1999) 1.60
The concept of coupling blood flow to brain function: revision required? Ann Neurol (1987) 1.58
Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies. Histochemistry (1986) 1.57
Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol (1979) 1.54
Pharmacological characterization of adrenergic alpha and beta receptors mediating the vasomotor responses of cerebral arteries in vitro. Circ Res (1974) 1.46
Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia (2010) 1.45
Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man. Circ Res (1978) 1.42
Endogenous hypergastrinaemia does not promote growth of colonic mucosa or of a transplanted colon adenocarcinoma in rats. Eur J Gastroenterol Hepatol (1998) 1.42
Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res (1976) 1.42
Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41
Biological evaluation of substance P antagonists. Br J Pharmacol (1984) 1.39
S-enantiomer of the selective serotonin reuptake inhibitor citalopram compared with racemate citalopram (S+R). Pharmacol Toxicol (2001) 1.39
The role of endogenous gastrin in the activation of gastric histidine decarboxylase in the rat. Effect of antrectomy and vagal denervation. Eur J Pharmacol (1970) 1.34
Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther (1985) 1.34
Multiple tachykinin pools in sensory nerve fibres in the rabbit iris. Neuroscience (1987) 1.32
Peptidergic (substance P) nerves in the genito-urinary tract. Neuroscience (1978) 1.31
Cellular localization of histamine and monoamines in the gastric mucosa of man. Histochemie (1969) 1.30
Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett (1985) 1.29
Peptidergic (enkephalin) innervation of the mammalian esophagus. Gastroenterology (1980) 1.27
Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res (1976) 1.27
Correlation between serum gastrin concentration and rat stomach histidine decarboxylase activity. J Physiol (1974) 1.27
Fluorometric determination of histamine with OPT: optimum reaction conditions and tests of identity. Anal Biochem (1972) 1.27
Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry (1975) 1.27
A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept (2001) 1.26
Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept (1984) 1.26
The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia. J Physiol (1988) 1.25
Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology (1983) 1.25
The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br J Pharmacol (2000) 1.23
Peptide-containing nerve fibers in the stomach wall of rat and mouse. Gastroenterology (1985) 1.23
Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology (1990) 1.23
Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept (1986) 1.22
Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. J Physiol (1981) 1.22
Concomitant histochemical demonstration of histamine and catecholamines in enterochromaffin-like cells of gastric mucosa. Life Sci (1967) 1.22
Amine mechanisms in the cerebral circulation. Pharmacol Rev (1976) 1.21
Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut. Cell Tissue Res (1977) 1.20
A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye. Science (1981) 1.20
Suppression of rat stomach histidine decarboxylase activity by histamine: H2-receptor-mediated feed-back. J Physiol (1977) 1.20
Duodenal endocrine cells in adult coeliac disease. Gut (1979) 1.19
Neurogenic mechanisms in the cerebrovascular bed. Autonomic nerves, amine receptors and their effects on cerebral blood flow. Acta Physiol Scand Suppl (1975) 1.19
Galanin: neuromodulatory and direct contractile effects on smooth muscle preparations. Br J Pharmacol (1985) 1.19
Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Neuron (1994) 1.19
Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract. Cell Tissue Res (1983) 1.18
Immunoreactive pancreatic polypeptide (PP) occurs in the central and peripheral nervous system: preliminary immunocytochemical observations. Cell Tissue Res (1979) 1.18
Improved fluorometric assay of histamine: condensation with O-phthalaldehyde at -20 degrees C. Anal Biochem (1974) 1.18
Nerve fibers in the gut and pancreas of the rat displaying neuropeptide-Y immunoreactivity. Intrinsic and extrinsic origin. Cell Tissue Res (1983) 1.17
The peptidergic innervation of the human superficial temporal artery: immunohistochemistry, ultrastructure, and vasomotility. Peptides (1995) 1.17
Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett (1983) 1.17
Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells. Cell Tissue Res (1975) 1.16
Projections of peptide-containing neurons in rat small intestine. Neuroscience (1987) 1.16
Proliferation of enterochromaffinlike cells in omeprazole-treated hypergastrinemic rats. Gastroenterology (1989) 1.16
Projections of peptide-containing neurons in rat colon. Neuroscience (1988) 1.16
Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience (2010) 1.15
Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand (1985) 1.15
Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol (1994) 1.15
Control of gastric acid secretion:the gastrin-ECL cell-parietal cell axis. Comp Biochem Physiol A Mol Integr Physiol (2001) 1.15
Galanin nerve fibers in the rat gut: distribution, origin and projections. Neuroscience (1985) 1.15
Neuropeptide Y receptor subtypes, Y1 and Y2. Ann N Y Acad Sci (1990) 1.15
Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience (1992) 1.14